FTO negatively regulates the cytotoxic activity of natural killer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Seok-Min | - |
dc.contributor.author | Oh, Se-Chan | - |
dc.contributor.author | Lee, Sun-Young | - |
dc.contributor.author | Kong, Ling-Zu | - |
dc.contributor.author | Lee, Jong-Hee | - |
dc.contributor.author | Tae-Don Kim | - |
dc.date.accessioned | 2023-04-10T22:00:15Z | - |
dc.date.available | 2023-04-10T22:00:15Z | - |
dc.date.created | 2023-03-06 | - |
dc.date.issued | 2023-04 | - |
dc.identifier.issn | 1469-221X | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/13215 | - |
dc.description.abstract | N-6-Methyladenosine (m(6)A) is the most abundant epitranscriptomic mark and plays a fundamental role in almost every aspect of mRNA metabolism. Although m(6)A writers and readers have been widely studied, the roles of m(6)A erasers are not well-understood. Here, we investigate the role of FTO, one of the m(6)A erasers, in natural killer (NK) cell immunity. We observe that FTO-deficient NK cells are hyperactivated. Fto knockout (Fto(-/-)) mouse NK cells prevent melanoma metastasis in vivo, and FTO-deficient human NK cells enhance the antitumor response against leukemia in vitro. We find that FTO negatively regulates IL-2/15-driven JAK/STAT signaling by increasing the mRNA stability of suppressor of cytokine signaling protein (SOCS) family genes. Our results suggest that FTO is an essential modulator of NK cell immunity, providing a new immunotherapeutic strategy for allogeneic NK cell therapies. | - |
dc.language | 영어 | - |
dc.publisher | WILEY | - |
dc.title | FTO negatively regulates the cytotoxic activity of natural killer cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000928849400001 | - |
dc.identifier.scopusid | 2-s2.0-85147312984 | - |
dc.identifier.rimsid | 80189 | - |
dc.contributor.affiliatedAuthor | Tae-Don Kim | - |
dc.identifier.doi | 10.15252/embr.202255681 | - |
dc.identifier.bibliographicCitation | EMBO REPORTS, v.24, no.4 | - |
dc.relation.isPartOf | EMBO REPORTS | - |
dc.citation.title | EMBO REPORTS | - |
dc.citation.volume | 24 | - |
dc.citation.number | 4 | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | MESSENGER-RNA METHYLATION | - |
dc.subject.keywordPlus | HEMATOPOIETIC STEM | - |
dc.subject.keywordPlus | FAT MASS | - |
dc.subject.keywordPlus | M(6)A | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | DEMETHYLASE | - |
dc.subject.keywordPlus | PROTEINS | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordAuthor | epitranscriptome | - |
dc.subject.keywordAuthor | FTO | - |
dc.subject.keywordAuthor | m(6)A regulator | - |
dc.subject.keywordAuthor | N6-methyladenosine | - |
dc.subject.keywordAuthor | NK cell | - |